MAPT and Alzheimer disease: Regarding GSK-3β, attenuation of the phosphatidylinositol 3-kinases/Akt (PI3K/Akt) pathway, as reported in AD, causes GSK-3β activity increase leading to Tau hyperphosphorylation and progression of AD [229].